40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)

NCT00159783 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: asenapine
DRUG: Olanzapine

Sponsor

Organon and Co

Collaborators

[object Object]